Drug Type Biosimilar, Fusion protein |
Synonyms Recombinant Human Tumor Necrosis Factor-α Receptor II(Hisun Bio Pharmaceutical), Recombinant Human Tumor Necrosis Factor-α Receptor II:IgG Fc Fusion Protein(Hisun Bio Pharmaceutical), Recombinant human type II tumor necrosis factor receptor-antibody fusion protein(Hisun Bio Pharmaceutical Co., Ltd.) + [3] |
Target |
Mechanism LTα inhibitors(Tumor necrosis factor β inhibitors), TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Ankylosing Spondylitis | CN | - | |
Ankylosing Spondylitis | CN | - | |
Psoriasis | CN | - | |
Psoriasis | CN | - | |
Rheumatoid Arthritis | CN | - | |
Rheumatoid Arthritis | CN | - |
Not Applicable | - | Recombinant Human Tumor Necrosis Factor-α ReceptorII:IgG Fc Fusion Protein (rhTNFRFc) | skauunttom(svgbkzkeul) = proazfozhv wilxzwllvh (fqyaqwxqon, 0.34) View more | - | 06 Jun 2012 | ||
Monocrotaline (MCT) | skauunttom(svgbkzkeul) = bsgrpalqrt wilxzwllvh (fqyaqwxqon, 0.65) View more |